Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Jul 15.
Published in final edited form as: Dev Biol. 2007 May 3;307(2):227–236. doi: 10.1016/j.ydbio.2007.04.036

Essential Roles of Mesenchyme-Derived Beta-Catenin in Mouse Müllerian duct Morphogenesis

Erica Deutscher 1, Humphrey Hung-Chang Yao 1
PMCID: PMC2020447  NIHMSID: NIHMS27348  PMID: 17532316

Abstract

Members of the Wnt family of genes such as Wnt4, Wnt5a, and Wnt7a have been implicated in the formation and morphogenesis of the Müllerian duct into various parts of the female reproductive tract. These WNT ligands elicit their action via either the canonical WNT/beta-catenin or the non-canonical WNT/Calcium pathway and could possibly function redundantly in Müllerian duct differentiation. By using the Müllerian duct specific anti-Müllerian hormone receptor 2 cre (Amhr2-cre) mouse line, we established a conditional knockout model that removed beta-catenin specifically in the mesenchyme of the Müllerian duct. At birth, loss of beta-catenin in the Müllerian duct mesenchyme disrupted the normal coiling of the oviduct in the knockout embryo, resembling the phenotype of the Wnt7a knockout. The overall development of the female reproductive tract was stunted at birth with a decrease in proliferation in the mesenchyme and epithelium. We also discovered that Wnt5a and Wnt7a expression remained normal, excluding the possibility that the phenotypes resulted from a loss of these WNT ligands. We examined the expression of Frizzled (Fzd), the receptors for WNT, and found that Fzd1 is one receptor present in the Müllerian duct mesenchyme and could be the putative receptor for beta-catenin activation in the Müllerian duct. In summary, our findings suggest that mesenchymal beta-catenin is a downstream effector of Wnt7a that mediates the patterning of the oviduct and proper differentiation of the uterus.

Keywords: anti-Müllerian hormone receptor 2 (Amhr2), beta-catenin, female reproductive tract, Frizzled, Müllerian duct, oviduct, Wnt

INTRODUCTION

The Müllerian duct is the embryonic precursor of the female reproductive tract. In the mouse, the Müllerian duct begins to form as an invagination of the surface epithelium of the mesonephros at embryonic day 11.5 or E11.5 and continues to elongate until it reaches the cloaca at E13.5 in both male and female embryos (Kobayashi and Behringer 2003). The transformation of the Müllerian duct into various parts of the female reproductive tract does not occur until later in embryonic development. By two weeks after birth in the mouse, the Müllerian duct has developed rostral-caudally into the oviducts, uterus, cervix, and upper portion of the vagina (Yin and Ma 2005). Formation of the Müllerian duct results from a collective action of transcription factors and signaling molecules including Pax2, Lim1, Emx2, and Wnt4 (Torres et al. 1995; Kobayashi et al. 2003; Miyamoto et al. 1997; Vainio et al. 1999). In embryos lacking either Pax2, Lim1, or Emx2, which are transcription factors expressed in the Müllerian duct epithelium, the Müllerian duct failed to form leading to a complete absence of the female reproductive tract (Torres et al. 1995; Kobayashi et al. 2003; Miyamoto et al. 1997). Wnt4, a signaling molecule produced by the Müllerian duct mesenchyme, is also essential for the initial formation of the Müllerian duct (Vainio et al. 1999).

The transformation of the Müllerian duct into distinct structures of the female reproductive tract also requires a coordinate interaction among transcription factors and local signaling molecules. Expression of the homeobox genes such as Hoxa9, Hoxa10, Hoxa11, and Hoxa13, are restricted to specific regions of the female reproductive tract after birth and null mutations of these homeobox genes lead to various defects in Müllerian duct patterning. A Hoxa10 mutation resulted in homeotic transformation; the anterior segment of the uterus transformed into the oviduct (Benson et al. 1996). In Hoxa10+/-; Hoxa11+/- embryos, abnormal uterotubal junctions and a narrow uterus arose (Branford et al. 2000). Furthermore, Hoxa13 female mutants were infertile, which was proposed to be due to hypoplasia of the vaginal cavity and the cervix (Post and Innis 1999). Overall, mutations in this set of Hox genes disrupt the regional specification of the female reproductive tract.

In addition to homeobox genes, signaling molecules such as Wnt5a and Wnt7a have been shown to be critical for the patterning of the Müllerian duct. Wnt5a is expressed in the mesenchyme of the uterus, cervix and vagina (Miller et al. 1998). In the absence of Wnt5a, the uterus did not develop uterine glands and the anterior/posterior structures such the cervix and vagina did not form properly (Mericskay et al. 2004). In contrast to the mesenchyme expression of Wnt4 and Wnt5a, Wnt7a is produced specifically in the luminal epithelium (Miller et al. 1998). Without Wnt7a, the oviducts failed to coil and the uterine wall was thinner and less muscular in the mutants as compared with wild type mice. Wnt7a mutants also lacked uterine glands and developed shallow vaginal fornices (Carta and Sasson 2004; Miller et al. 1998).

WNT proteins are known to elicit their function through two pathways in a ligand- and receptor-dependent manner: the canonical WNT/beta-catenin pathway and the non-canonical WNT/Ca2+ pathway (Miller 2001). The concurrent presence of Wnt4, Wnt5a, and Wnt7a in the Müllerian duct suggests a certain degree of redundancy among these WNTs in Müllerian duct patterning. In this study, we investigated the overall role of the canonical WNT pathway by removing beta-catenin specifically in the mesenchyme of the Müllerian duct that express Amhr2. By comparing the Müllerian duct phenotypes of the mesenchyme-specific beta-catenin knockout with other Wnt knockouts, we were able to establish a connection between these WNT ligands and the canonical WNT pathway during female reproductive tract differentiation.

MATERIALS AND METHODS

Animals, Breeding Scheme, and Mating

Amhr2cre/+ or Amhr2-Cre mice were generously provided by Dr. Richard Behringer (Jamin et al. 2002). B6.Cg-Tg(ACTB-Bgeo/GFP)21Lbe (or Z/EG, Jax #004178), B6.FVB-TgN(EIIa-Cre)C5379Lmgd (or EIIa-Cre, Jax #003314) and B6.129-Catnb1tm2Kem/J (or Catnbfloxed/floxed, Jax#004152) were obtained from the Jackson Laboratory. To increase the efficiency in the production of homozygous null alleles and to decease the incidence of mosaic deletion, we generated Amhr2cre/+;Catnbfloxed/- embryos by crossing Amhr2cre/+;Catnb+/- mice to Amhr2+/+;Catnbfloxed/floxed mice. Female mice were placed with male mice in the late afternoon and checked for the presence of vaginal plugs the next morning. Mating was assumed to occur at the midpoint of the dark cycle and therefore noon of the following day was considered 0.5 days of gestation, or embryonic day 0.5 (E0.5). Samples were collected at E15.5, birth (P0), and 60 days after birth (P60). For genotyping, tail bits were digested in 50mM Sodium Hydroxide and subjected to standard PCR for gene-specific primers as described (Brault et al. 2001; Jamin et al. 2002). All procedures described were reviewed and approved by the Institutional Animal Care and Use Committee, and were performed in accordance with the Guiding Principles for the Care and Use of Laboratory Animals.

Histology

Tissues were fixed in 4% paraformaldehyde in PBS at 4°C overnight and then dehydrated for paraffin embedding. Samples were sectioned to 4 μm thickness and rehydrated for Hematoxylin and Eosin (H&E) staining. Slides were cover-slipped with Permount.

Ki67 Immunostaining for proliferation

Samples were fixed in 4% paraformaldehyde in PBS at 4°C overnight. The next day, samples were rinsed in PBS. Then samples were put through a sucrose gradient of 10%, 15%, and 20%, and then 20% sucrose in PBS and OCT freezing media (Tissue-Tek) in a 1:1 ratio overnight at 4°C. The samples were embedded in 20% sucrose in PBS and OCT freezing media (1:3) and cut at 10 μm sections. Samples were quenched in 0.6% hydrogen peroxide in methanol. Then samples were rinsed in running tap water. For antigen retrieval, samples were put in a sodium citrate solution and microwaved. Next samples were rinsed in running tap water followed by PBS. Blocking solution with 10% donkey serum was added to the slides for 30 minutes at room temperature. Then the primary antibody against Ki67 (mouse, 1:500, BD Pharmingen) was diluted in PBS and incubated overnight at 4°C. The following day, samples were rinsed in PBS. Then the secondary antibody (Donkey anti-mouse IgG, Jackson Immunologicals) was diluted in 5% serum and allowed to incubate on the samples for 1 hour at room temperature. For the color development, 250 μl of DAB, 50 μl of Tris buffer and 8.5 μl (30%) hydrogen peroxide was applied to the samples. Upon the completion of color development, the samples were rinsed in tap water for 1 minute and counterstained in Hematoxylin for 15 seconds. Then the samples were washed in running tap water and mounted.

Whole mount in situ hybridization

Tissues were fixed overnight with 4% paraformaldehyde in PBS at 4°C and processed according to the standard non-radioisotopic procedure using digoxigenin-labeled RNA probes. The sources of RNA probes and their optimal hybridization temperature are as follows: Frizzled1, -2, and -7 (70°C, from Dr. Sam Pleasure) and Wnt5a and 7a (70°C, from Dr. Andrew McMahon).

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)

To detect the presence of mRNA for Frizzled 1 to 8 in the mesonephros, total RNA from 20 E14.5 female mesonephroi were isolated using Trizol reagent. Before the reverse transcriptase (RT) reaction, 1 μl of RNA was treated with 1 μl of DNase, 1 μl of buffer, and 7 μl of DEPC-water. Then 1 μl of stop solution was added to the mixture and incubated at 65°C. This solution was used for the RT reaction. The reverse transcriptase reaction was carried out using 5 μl of RNA, 2 μl of buffer, 0.5 μl of random primers, 2 μl of 10mM dNTP, 1 μl of reverse transcriptase, and 9.5 μl of DEPC-water following these steps: 42°C for 1 hour and 95°C for 5 minutes. An RT free control was run with all of the above reagents minus the reverse transcriptase enzyme along with a no template control which has all of the above reagents minus the RNA. Finally, 80 μl of DEPC-water was added to the final reaction mixture. For the PCR reaction for specific Frizzled receptors, 12.5 μl of Taq polymerase, 1.25 μl of primers (primer sequences for various Frizzled receptors were based on information published by Hsieh et al. 2002; Mfz-1: forward 5′-ACCCTGCGAACCCACCAAGGTTTA-3′, reverse 5′-CCGTCCTCTG CAAACTTGTCGTT-3′; Rfz-2: forward 5′-ACGGAACTCCTGCGCT ACTCACCA-3′, reverse 5′-ATAACCGTCCTCAGAGAAGCGCTC-3′; Mfz-3: forward 5′-CCGTACCAGGT TACTCAGATGAGT, reverse 5′-GCACTGGTTCCATCCTCC TCAATA-3′; Mfz-4: forward 5′-CTGGGCACTCTTTCGATATTCTGC-3′, reverse 5′-TCCAAGCTGTGACCTGCT AAAGTG; Mfz-5: forward 5′-GACGCCGAGGTTCTG TGTAT-3′, reverse 5′-TGCGCAC CTTGTTGTAGAGT-3′; Mfz-6: forward 5′-CAGGCAAATCCAAAAGCTC GACCA-3′, reverse 5′-GGGGAGGTGTGGACTTC TGTTGAA-3′; Mfz-7: forward 5′-CAGACTTGCA GAGCTACGCTGTG-3′, reverse 5′-CACTTCCAGGTTAAAGCTCAG TGG-3′; Mfz-8: forward 5′-CCACGCACAACTGCC CATGCCTT-3′, reverse 5′-CATGCTATAGCAGTCA ACACTGGG-3′), 10.25 μl of double distilled water, and 1 μl of cDNA were mixed and subjected for PCR cycles (30 cycles for 94°C 1 min, 60°C 2 min, and 72°C 3 min). PCR reactions using 36B4 primers were performed on the RT, RT free, and no template samples to ensure proper reverse transcription occurred. RNA from adult ovaries was also used as a positive control for various Fzds. Following the PCR reaction, samples were run on a 1.5% TAE gel.

Imaging

Light microscopy pictures for whole mount in situ hybridization and macroscopic pictures of tissues were taken with the Leica DFC320 camera with a Zeiss Stemi SV11 microscope using ImagePro Discovery Software. Fluorescent pictures were taken with the Axiocam MRm Zeiss microscope using the X-Cite 120 fluorescence illumination system. Histological pictures were taken with the Olympus BX51 microscope using Progres C14 Olympus camera and software. All images were subsequently refined in Adobe Photoshop.

RESULTS

Phenotypes in the female reproductive tract of Amhr2cre/+; Catnbfloxed/- embryos

We utilized the Amhr2-Cre mouse line to target Cre recombinase in the mesenchyme of the Müllerian duct (Jamin et al. 2002). Previous reports indicated that the activity of the Cre recombinase was detected in the Müllerian duct mesenchyme as early as E12.5 using the ROSA reporter mice (Jamin et al. 2002). To determine the efficiency of Cre recombination in our hands, we crossed the Amhr2-Cre line to the Cre reporter line Z/EG (or B6.Cg-Tg(ACTB-Bgeo/GFP)21Lbe, Novak et al. 2000), which expresses Enhanced Green Fluorescent Protein (EGFP) upon Cre recombination. We found that EGFP began to appear in the Müllerian duct mesenchyme at E15.5 (Fig. 1A & B), about 72 hours later than originally reported. This delayed detection of Amhr2-Cre activity could result from the time required for proper folding of EGFP or the accessibility of the reporter construct to the Cre recombinase. Based on our results and previous findings, it is certain that by E15.5, Amhr2-Cre has become active and most importantly not all cells in the mesenchyme were positive for Cre activity at this stage (Fig. 1B)

Figure 1. Phenotypic differences in the female reproductive tract between Amhr2cre/+;Catnbfloxed/+ (A-F) and Amhr2cre/+;Catnbfloxed/- (G-L) animals at birth.

Figure 1

(A & B) Amhr2-Cre activity indicated as EGFP fluorescent staining in the mesonephros of E15.5 Z/EG reporter female embryos. (B, 20X) is a zone-in picture of the white rectangle area in (A, 4X). Light microscopic images of the female reproductive tract were obtained at birth or P0 (C, F, I, L) and at 2 months of age or P60 (G & M). (D, E, J, & K) are H&E staining of cross sections with the same magnification (20X) from utero-oviductal junctions and middle uterine horns (indicated by the brackets) at birth, respectively. (H & N) are cross-sections of upper uterine horns at birth immunostained for Ki67. Brown nuclear deposits indicate specific staining and blue nuclear staining is a hematoxylin counter stain (magnifications are 10X for the original & 100X for the rectangle amplification). O = ovary; OD = oviduct; U, uterine horns. The sample size was N=6 for each genotype.

To increase the efficiency in the production of homozygous beta-catenin (Catnb) null alleles and to decease the incidence of mosaic deletion, we generated Amhr2cre/+; Catnbfloxed/- embryos by crossing Amhr2cre/+;Catnb+/- mice to Amhr2+/+;Catnbfloxed/floxed mice. Reproductive tracts of the female Catnb conditional knockout and control litter mates (Amhr2cre/+;Catnbfloxed/+) were first examined at birth. The uterine horns of the knockout newborns (Fig. 1I, N=6 for all experiments) were hypotrophic as compared with the control (Fig. 1C). The oviducts of the knockout newborn lacked the characteristic coiling which was apparent in the control (Fig. 1F & L). The lack of oviduct coiling was distinctly apparent in the adult conditional knockout at two months of age (Fig. 1G & M). The defect on oviduct differentiation was also evident at the cellular level. We obtained cross sections from the utero-oviduct junction (Fig1. D & J) and uterine horn (Fig1. E & K) at birth and performed H&E stain. While the epithelial layer of the utero-oviductal junction differentiated into the typical mucosal folding in the control (Fig. 1D), the mucosal folding of the epithelial layer was completely absent in the knockout (Fig. 1J). Other parts of the uterine horn appeared to develop similarly in both the control and knockout animals with the exception of the size difference (Fig. 1E & K). The circumference of the uterine horn in the knockout newborn was smaller than the control, consistent with the phenotypic size differences. In summary, loss of Catnb in the Amhr2-positive Müllerian duct mesenchyme in embryos resulted in uterine horn hypotrophy and loss of oviduct coiling.

We also generated Amhr2cre/+; Catnbfloxed/floxed embryos as previously described (Arango et al. 2005) and compared them to the Amhr2cre/+; Catnbfloxed/- embryos. At birth, the Amhr2cre/+; Catnbfloxed/floxed embryos exhibited much less severe phenotypes than the Amhr2cre/+; Catnbfloxed/- embryos. Although hypotrophy of the uterine horn was apparent, the oviduct coiling was present in the Amhr2cre/+; Catnbfloxed/floxed embryos, which is in contrast to the loss of the oviduct structure in the Amhr2cre/+; Catnbfloxed/- embryos (data not shown). This observation confirmed our concern that Amhr2-Cre may not be efficient enough to remove two floxed Catnb alleles in the previously reported model to reveal defects on early Müllerian duct patterning (Arango et al. 2005).

Differences in cell proliferation in the Müllerian ducts between control and Amh2cre/+; Catnbfloxed/- embryos

To understand what contributed to the hypotrophic phenotypes in the Catnb conditional knockout, we examined cell proliferation and apoptosis. Using immunocytochemistry for Ki67, a marker for proliferation, we found that the Catnb knockout female reproductive tract had fewer Ki67 positive cells in both the mesenchyme and the epithelium compartments as compared with the control at birth (Fig. 1H & N, N=6). TUNEL assay revealed no differences in apoptosis in either the mesenchyme or the epithelium between the control and knockout samples (data not shown). In conclusion, the absence of Catnb in the Müllerian duct mesenchyme in embryos led to a decrease in proliferation in both the epithelium and the mesenchyme of the female reproductive tract but had no effect on cell survival at birth.

Expression of Wnt5a and Wnt7a in the Amh2cre/+; Catnbfloxed/- Müllerian duct

The lack of oviduct coiling in the Catnb conditional knockout female closely resembled the phenotypes in the Wnt7a knockout (Parr and McMahon 1998). This suggested that the oviduct phenotypes in our Catnb conditional knockout could result from loss of Wnt7a expression. To test this possibility, we examined the expression of Wnt7a as well as Wnt5a, another Wnt important in female reproductive tract development. Whole mount in situ hybridization on E15.5 and E19.5 mesonephroi revealed that expression patterns of Wnt5a and Wnt7a were not altered in the absence of mesenchymal Catnb (Fig. 2). These results indicated that the phenotypes in the Catnb conditional knockout resulted from a loss of Catnb, not the loss of Wnt5a or Wnt7a.

Figure 2. Whole mount in situ hybridization for Wnt5a (A) and Wnt7a (B) on Amhr2cre/+;Catnbfloxed/+ (Control) and Amhr2cre/+;Catnbfloxed/- (Knockout) mesonephroi at E15.5 and E19.5.

Figure 2

The entire mesonephros was shown for E15.5 samples whereas only a small segment of the mesonephros was shown for the E19.5 samples. Dark purple/brownish deposits represent specific staining. White arrows point to the Müllerian duct. White scale bars represent 100 microns. The sample size was N=5 for each genotype.

Expression of Frizzled receptors in the normal female mesonephros

In both the canonical and non-canonical WNT signaling pathways, the WNT ligand binds to its receptor Frizzled (FZD). At present, ten Fzd receptors have been found in the mouse, and their expression during Müllerian duct differentiation has yet to be described. To identify the Fzd(s) that may be responsible for activating the canonical or WNT/beta-catenin pathway, we performed RT-PCR for Fzd receptors 1-8 on RNA isolated from E14.5 female mesonephroi. Fzd9 and Fzd10 were not examined as their expression patterns have been characterized in the mesonephros (Nunnally and Parr, 2004; Wang et al., 1999) and no apparent phenotypes were observed in the individual knockout (Fzd9: MGI Direct Data Submission MGI:3609573; Zhao et al. 2005; Ranheim et al. 2005; Fzd 10: MGI Direct Data Submission MGI:3604450). E14.5 was chosen because this is the point when the Müllerian duct is fully formed in the female. We found that mRNA for Fzd1, 2, and 7 were present in the female mesonephroi at E14.5 (Fig. 3A, N=3). RNA from adult ovaries was used as positive controls for each Fzd to demonstrate the specificity and correct amplification of the PCR products (Hsieh et al. 2002).

Figure 3. Expression of Fzd receptors in the female mesonephroi at E14.5.

Figure 3

(A) Reverse transcriptase PCR was performed on RNA isolated from E14.5 female mesonephroi using primers for Fzd1-8. For each Fzd, the left lane represents the female mesonephros (M) while the right lane is the adult ovary positive control (O). (B) Whole mount in situ hybridization for Fzd1, Fzd2, and Fzd7 was performed on E14.5 female mesonephroi. Dark purple/brownish deposits represent specific staining. Arrows indicate the Müllerian duct epithelium and the black arrowhead indicates the Müllerian duct mesenchyme. The Wolffian duct mesenchyme is marked by the asterisk. The sample size was N=3. (C) Section in situ hybridization for Fzd1, Fzd2, and Fzd7 of a cross-section of the mesonephros countered with nuclear fast red. Arrow and arrowhead indicate Müllerian duct epithelium and mesenchyme, respectively. MD = Müllerian duct; MM = Müllerian duct mesenchyme.

To identify the cellular compartments of Fzd expression in the mesonephros, we preformed whole mount (Fig. 3B) and section (Fig. 3C) in situ hybridization for Fzd1, -2, and -7. In the E14.5 mesonephros, Fzd1 mRNA was detected in both the epithelium and the mesenchyme of the Müllerian duct (Fig. 3B & C arrow and arrowhead, respectively). On the other hand, low Fzd2 and high Fzd7 expression was not detected in either the Müllerian duct epithelium or mesenchyme (Fig. 3B, asterisks). Arrows in forFzd2 and Fzd7 in Fig. 3B indicate the outline of the Müllerian duct due to the artifact of lighting. No staining was found in the duct or mesenchyme.

Phenotypes in female tracts of adult Amh2cre/+; Catnbfloxed/- animals

Previous observations using the Amh2cre/+; Catnbfloxed/floxed model revealed that the uterine smooth muscle cells underwent a myogenesis to adipogenesis transformation postnatally (Arango et al. 2005). We found this similar phenotype in the Amh2cre/+; Catnbfloxed/- model macroscopically (Fig. 4A & E) and microscopically (Fig. 4B, C, F, & G). The longitudinal myometrium in the knockout was lost with infiltration of adipose tissue. However, part of the transverse myometrium and the uterine glands were still present (Fig. 4C & G). In addition to this phenotype, we observed a unique defect in which the ovary of the Catnb conditional knockout was enclosed in a liquid-filled sac (Fig. 4E & H, n=6). We speculate that the sac was the derivative of ovarian bursa and the fluid was the accumulation of follicular fluids after ovulation.

Figure 4. Phenotypes in the adult female reproductive tracts of Amhr2cre/+;Catnbfloxed/+ (A-D) and Amhr2cre/+;Catnbfloxed/- (E-H) animals at two months of age.

Figure 4

(A & E) are light microscopic images (1.6X) of whole mount female reproductive tracts. White arrows indicate the nodule structure with fat accumulation in the knockout sample. Asterisks indicate the fluid-filled sac surrounding the ovary in the knockout animal. FP = fat pad; O = ovary; OD = oviduct; U, uterine horns. (B & F) are H&E staining on section of the uterus (magnification = 8X). (C & G) are higher magnification (20X) of the rectangle regions of the B & F, respectively. The brackets outline the two layers of the myometrium (transverse and longitudinal). Black arrowheads indicate the uterine glands. Ad = adipose tissues; En = endometrium; L = longitudinal myometrium; T = transverse myometrium. (D & H) are H&E staining on sections of ovaries (magnification = 8X). Asterisks indicate the liquid-filled sac. The sample size was N=6 for each genotype.

DISCUSSION

The morphogenesis of the Müllerian duct into the various parts of the female reproductive tract requires intricate interactions among transcription factors and signaling molecules. Without the proper differentiation of the Müllerian duct in the female and its regression in the male, reproductive tract anomalies and infertility can occur. In the mouse, several Wnts including Wnt4, Wnt5a, and Wnt7a are expressed in a compartment-specific manner in the Müllerian duct and play unique roles in regional specific development of the duct. Wnt4 and Wnt5a are expressed in the mesenchyme of the Müllerian duct while Wnt7a is expressed in the epithelium of the Müllerian duct (Miller et al. 1998). These WNTs signal through the canonical beta-catenin pathway, the non-canonical WNT pathway, or a combination of both. Wnt4 has been found to activate both the canonical and the non-canonical WNT signaling pathways in vertebrate tissues such as the kidney, the Müllerian duct, and the mammary gland (Stark, 1994; Vainio et al. 1999; Brisken 2000). Wnt5a mainly signals through the non-canonical pathway in vertebrate species in the limb, the lung, chondrocytes, and the female reproductive tract (Yamaguchi 1999; Li 2006; Yang 2003; Mericskay et al. 2004). On the other hand, Wnt7a elicits its action through the canonical WNT pathway in vertebrates in the limb, the female reproductive tract, and the cerebellum (Parr 1995; Parr 1998; Miller 1998; and Hall 2000). To understand the overall role of the canonical WNT pathway in Müllerian duct development, we removed beta-catenin specifically in the Amhr2-expressing mesenchyme of the Müllerian duct and investigated how the WNT/beta-catenin pathway connected to various WNT molecules in this developmental process.

The oviduct phenotype in the Catnb conditional knockout resembles Wnt7a null phenotypes

One of the most intriguing phenotypes in our model is the loss of oviduct coiling. Similar phenotypes were also observed in Wnt7a null mice (Mericskay et al. 2004; Parr and McMahon 1998). These results suggest that Wnt7a mediates the transformation of anterior Müllerian duct into characteristic oviduct coiling through beta-catenin (Fig. 5). The phenotypes of our model did not resemble the phenotypes in the Wnt5a knockout, indicating that Wnt5a may not signal via beta-catenin in the Müllerian duct mesenchyme. The similar phenotypes between Wnt7a mutants and our Catnb conditional knockout model raise the possibility that the Wnt7a pathway could be affected in the absence of Catnb. However, we did not detect any changes in the expression pattern of Wnt5a and Wnt7a. Therefore, we conclude that expression of Wnt5a and Wnt7a does not require the presence of mesenchymal Catnb. Furthermore, the oviduct phenotypes in our Catnb conditional knockouts did not result from the loss of Wnt5a and Wnt7a.

Figure 5. A hypothetical model for the role of beta-catenin on Müllerian duct morphogenesis.

Figure 5

Based on the similar and different defects in Wnt7a-/- and Amhr2cre/+;Catnbfloxed/- newborns, we propose that WNT7a, which is produced by the Müllerian duct epithelium, acts on the Amhr2-positive mesenchyme cells and activates the canonical WNT/beta-catenin pathway, probably via the Fzd1 receptor, in a regional specific manner. In the anterior Müllerian duct, the future oviduct, activation of the canonical WNT/beta-catenin pathway via WNT7a leads to proliferation and proper differentiation of the Müllerian duct mesenchyme. The WNT/beta-catenin pathway could also stimulate the production of unknown factors from the mesenchyme, which in turn regulates the proliferation of the Müllerian duct epithelium and oviduct coiling. In the middle Müllerian duct, the future uterus, WNT7a maintains proper myogenesis of the uterine myometrium via catenin. However, effects of WNT7a on uterine gland formation probably is not involved beta-catenin in the mesenchyme due to the fact that uterine glands still form when beta-catenin is inactive in the mesenchyme. . MD = Müllerian duct.

Due to the fact that the female reproductive tract still formed in the absence of mesenchymal beta-catenin, one would speculate that beta-catenin may not be involved in the pathway induced by Wnt4, which is essential for Müllerian duct formation (Vainio et al. 1999). However, in our conditional knockout system, removal of beta-catenin occurred relatively late at E15.5, a time that is almost 72 hours after formation of the Müllerian duct. Therefore, our model cannot address the question of whether beta-catenin is involved in early Müllerian duct formation. The connection between Wnt4 and beta-catenin in Müllerian duct development remains to be determined.

In addition to Wnts, Hox genes are also important patterning genes in the female reproductive tract, particularly in the differentiation of the oviducts and uterus. A possible interaction between these homeobox genes and WNTs has been proposed. In the Wnt7a knockout female reproductive tract, Hoxa10 and Hoxa11 expression was maintained at birth (Miller et al. 1998). However, at three months of age, Hoxa10 and Hoxa11 transcripts are no longer detected in the mutant Wnt7a uterus (Miller et al. 1998). Thus, it was concluded that Wnt7a is required to maintain normal Hox gene expression in the adult female reproductive tract (Miller et al. 1998). However in the embryo, WNT7a probably does not regulate Hoxa10 and Hoxa11 expression and their effects on Müllerian duct patterning. This was supported by the fact that these Hox genes were still expressed properly in Wnt7a null embryos at birth (Miller et al. 1998). This result indicated that the loss of oviduct coiling in the Wnt7a null (or our Catnb conditional knockout) newborn was not caused by the alteration of Hox gene expression. Instead, Wnt7a and beta-catenin probably directly control the patterning of the female reproductive tract independent of the Hox genes.

Presence of Catnb in the Müllerian duct mesenchyme is essential for proper proliferation in both mesenchymal and epithelial compartments

At birth, the female reproductive tract in the Catnb conditional knockout embryos were hypotrophic and less proliferation was found in both the mesenchyme and the epithelium as compared to the control. The defect in epithelial proliferation is intriguing because Catnb was removed exclusively in the mesenchyme. The defect on proliferation in both compartments suggests that there is a cross-talk between the epithelium and mesenchyme, and this cross-talk requires the presence of Catnb in the Müllerian duct mesenchyme. WNT signaling has been linked to the control of cellular proliferation in the vascular system (Escalante-Alcade et al. 2003). We propose that the signaling pathway downstream of beta-catenin in the mesenchyme causes production of unknown proliferation-inducing factor(s), which act as a paracrine signal to regulate epithelium expansion and morphogenesis (Fig. 5). The nature of the proliferation-inducing factor remains to be determined.

Studies in several organisms have revealed that WNT signaling may control apoptosis through different mechanisms including the WNT-BMP signaling loop (Golden et al. 1999), secreted Frizzled-related protein-2 (Ellies et al. 2000), and most importantly the WNT/beta-catenin signaling pathway (Galceran et al. 2000, Brault et al. 2001). However, we did not find any increase in apoptosis in the absence of Catnb, suggesting that the anti-apoptosis mechanism of beta-catenin does not appear to be involved in Müllerian duct differentiation.

Frizzled receptors 1, 2, and 7 are present in the developing mesonephros

To further understand the mechanism of how the canonical WNTs activate the beta-catenin pathway, we searched for the presence of specific Fzd receptors in the mesonephros. We discovered that Fzd1, -2, and -7 are all expressed at the time of Müllerian duct differentiation by RT-PCR. However, whole mount and section in situ hybridization revealed that only Fzd1 was expressed in both the epithelium and the mesenchyme of the Müllerian duct while Fzd2 and Fzd7 were not. Previous experiments have demonstrated that Fzd1 associates with WNT family members in the canonical WNT pathway (Logan and Nusse 2004). Transfection studies using Wnt7b and Fzd1 have shown that Fzd1 can induce the signal transduction of the WNT/beta-catenin pathway (Wang et al. 2005). Based on these experiments, as well as the mesenchyme expression of Fzd1, we speculate that Fzd1 could be involved in the canonical WNT/beta-catenin pathway in the Müllerian duct. Further examination of Fzd1 knockouts is needed to confirm its role on Müllerian duct patterning.

Unique phenotypes in adult Catnb conditional knockout females

A dramatic increase in adipose tissue deposition on the uterine horns in adulthood was evident in the Catnb conditional knockout female. This phenotype was consistent with the previous findings using a similar Catnb conditional knockout model (Arango et al. 2005). The major difference between our model and the previous model is that we introduced a null allele to the process of generating the conditional allele. Arango et al. examined the Amhr2cre/+;Catnbfloxed/floxed animals which yielded a true knockout only when both floxed alleles were removed. The introduction of the null allele in our experiments should theoretically enhance the efficiency in the production of homozygous null alleles because the Cre recombinase only has to remove one floxed allele. We have generated Catnb conditional knockout mice using these two different models and found that the phenotypes were less severe in Amhr2cre/+;Catnbfloxed/floxed as compared to the Amhr2cre/+;Catnbfloxed/-. The hypotrophy in the uterine horns was not as severe and the oviduct coiling was not affected. Introduction of one null allele in our model revealed a novel role of Catnb on Müllerian duct patterning, which was not evident in the study by Arango et al.

In conclusion, this study highlights an important role of beta-catenin on morphogenesis of the female reproductive tract, particularly the coiling of the oviduct. We propose that the presence of beta-catenin in the Amhr2-expressing cells in the anterior Müllerian duct mesenchyme is essential for transducing the canonical beta-catenin pathway induced by WNT7a (Fig. 5). The absence of beta-catenin not only adversely affects the oviduct patterning, but also continues this effect throughout adulthood by causing adipose tissue deposition in the uterine wall. However, the uterine glands were still present in the absence of beta-catenin, a phenotype different from the Wnt7a knockout where the uterine glands were lost. These results together demonstrate a unique connection between WNT7a and beta-catenin in establishment of the oviduct coiling in the anterior Müllerian duct. On the other hand, beta-catenin in the Amhr2-negative cells in mesenchyme of the middle Müllerian duct is probably not responsible for transducing WNT7a signal for the formation of uterine glands.

ACKNOWLEDGEMENT

The authors would like to thank Dr. Richard Behringer for providing the Amhr2-cre mice and March of Dimes Birth Defects Foundation (Basil O’Conner Starter Scholar Research Award #5-FY04-35 for H.H.Y.) and National Institute of Health (HD46861 for H.H.Y.) for their financial support. We also appreciate all the Yao lab members and Joan Thompson for their assistance and support.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

REFERENCES

  1. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 2005;288:276–283. doi: 10.1016/j.ydbio.2005.09.045. [DOI] [PubMed] [Google Scholar]
  2. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homoesis and loss of maternal Hoxa-10 expression. Dev. 1996;122:2687–2696. doi: 10.1242/dev.122.9.2687. [DOI] [PubMed] [Google Scholar]
  3. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R. A new member of the frizzled family from Drosophilia functions as a Wingless receptor. Nature. 1996;382:225–230. doi: 10.1038/382225a0. [DOI] [PubMed] [Google Scholar]
  4. Branford WW, Benson GV, Ma L, Maas RL, Potter SS. Characterization of Hoxa-10/Hoxa-11 transheterozygotes reveals functional redundancy and regulatory interactions. Dev. Bio. 2000;224:373–387. doi: 10.1006/dbio.2000.9809. [DOI] [PubMed] [Google Scholar]
  5. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O, Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletions results in dramatic brain malformation and failure of craniofacial development. Dev. 2001;128:1253–64. doi: 10.1242/dev.128.8.1253. [DOI] [PubMed] [Google Scholar]
  6. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 2000;14:650–4. [PMC free article] [PubMed] [Google Scholar]
  7. Carta L, Sassoon D. Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. Epub. 2004;71:444–54. doi: 10.1095/biolreprod.103.026534. [DOI] [PubMed] [Google Scholar]
  8. Du H, Taylor HS. Molecular regulation of Müllerian development by Hox genes. Ann N Y Acad Sci. 2004;1034:152–165. doi: 10.1196/annals.1335.018. [DOI] [PubMed] [Google Scholar]
  9. Ellies DL, Church V, Francis-West P, Lumsden A. The WNT antagonist cSFRP2 modulates programmed cell death in the developing hindbrain. Dev. 2000;127:5285–95. doi: 10.1242/dev.127.24.5285. [DOI] [PubMed] [Google Scholar]
  10. Escalante-Acalde D, Hernandez L, et al. The lipid phosphatase and LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Dev. 2003;130:4623–4637. doi: 10.1242/dev.00635. [DOI] [PubMed] [Google Scholar]
  11. Galcernan J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R. Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Dev. 2000;127:469–82. doi: 10.1242/dev.127.3.469. [DOI] [PubMed] [Google Scholar]
  12. Golden JA, Bracilovic A, McFadden KA, Beesley JS, Rubenstein JL, Grinspan JB. Ectopic bone morphogenetic proteins 5 and 4 in the chicken forebrain lead to cyclopia and holoprosencephaly. Proc Natl Acad Sci. 1999;96:2439–44. doi: 10.1073/pnas.96.5.2439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hall AC, Lucas FR, Salinas PC. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell. 2000;100:525–535. doi: 10.1016/s0092-8674(00)80689-3. [DOI] [PubMed] [Google Scholar]
  14. Hsieh M, Johnson MA, Greenberg NM, Richards JS. Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. Endocrinology. 2002;143:898–908. doi: 10.1210/endo.143.3.8684. [DOI] [PubMed] [Google Scholar]
  15. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet. 2002;32:408–410. doi: 10.1038/ng1003. [DOI] [PubMed] [Google Scholar]
  16. Kobayashi A, Behringer RR. Developmental genetics of the female reproductive tract in mammals. Nat Genet. 2003;4:969–980. doi: 10.1038/nrg1225. [DOI] [PubMed] [Google Scholar]
  17. Kobayashi A, Shawlot W, Kania A, Behringer RR. Requirement of Lim1 for female reproductive tract development. Dev. 2003;131:539–549. doi: 10.1242/dev.00951. [DOI] [PubMed] [Google Scholar]
  18. Li F, Chong ZZ, Maiese K. Winding through the WNT pathway during cellular development and demise. Histol Histopathol. 2006;21:103–124. doi: 10.14670/hh-21.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Logan C, Nusse R. The Wnt signaling pathway in development and demise. Annu Rev Cell Dev Biol. 2004;20:781–810. doi: 10.1146/annurev.cellbio.20.010403.113126. [DOI] [PubMed] [Google Scholar]
  20. Mericskay M, Kitajewski J, Sassoon D. Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Dev. 2004;131:2061–2071. doi: 10.1242/dev.01090. [DOI] [PubMed] [Google Scholar]
  21. Miller C, Degenhardt K, Sassoon DA. Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nat Genetics. 1998;20:228–230. doi: 10.1038/3027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller C, Pavlova A, Sassoon DA. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech. Dev. 1998;76:91–99. doi: 10.1016/s0925-4773(98)00112-9. [DOI] [PubMed] [Google Scholar]
  23. Miller J. The Wnts. Genome Biology. 2001;3:3001.1–3001.15. [Google Scholar]
  24. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. Defects of urogenital development in mice lacking Emx2. Dev. 1997;124:1653–1664. doi: 10.1242/dev.124.9.1653. [DOI] [PubMed] [Google Scholar]
  25. Novak A, Guo C, Yang W, Nagy A, Lobe CG. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 2000;28:147–151. [PubMed] [Google Scholar]
  26. Nunnally AP, Parr BA. Analysis of Fz10 expression in mouse embryos. Dev Genes Evol. 2004;214:144–8. doi: 10.1007/s00427-004-0386-4. [DOI] [PubMed] [Google Scholar]
  27. Parr B, McMahon A. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Letters to Nature. 1998 doi: 10.1038/27221. [DOI] [PubMed] [Google Scholar]
  28. Parr B, McMahon A. Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature. 1995;374:350–4. doi: 10.1038/374350a0. [DOI] [PubMed] [Google Scholar]
  29. Post LC, Innis JW. Infertility in adult hypodactyly mice is associated with hypoplasia of distal reproductive structures. Biol Reprod. 1999;61:1402–1408. doi: 10.1095/biolreprod61.6.1402. [DOI] [PubMed] [Google Scholar]
  30. Ranheim EA, Kwan HC, Reya T, Wang YK, Weissman IL, Francke U. Frizzled 9 knock-out mice have abnormal B-cell development. Blood. 2005;105:2487–94. doi: 10.1182/blood-2004-06-2334. [DOI] [PubMed] [Google Scholar]
  31. Stark K, Vainio S, Vassileva G, McMahon AP. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt4. Nature. 1994;372:679–683. doi: 10.1038/372679a0. [DOI] [PubMed] [Google Scholar]
  32. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax2 controls multiple steps of urogenital development. Dev. 1995;121:4057–4065. doi: 10.1242/dev.121.12.4057. [DOI] [PubMed] [Google Scholar]
  33. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signaling. Nature. 1999;397:405–409. doi: 10.1038/17068. [DOI] [PubMed] [Google Scholar]
  34. Wang YK, Sporle R, Paperna T, Schughart K, Francke U. Characterization and expression pattern of the frizzled gene Fzd9, the mouse homolog of FZD9 which is deleted in Williams-Beuren syndrome. Genomics. 1999;57:235–48. doi: 10.1006/geno.1999.5773. [DOI] [PubMed] [Google Scholar]
  35. Yamaguchi TP, Bradley A, McMahon AP, Jones S. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Dev. 1999;126:1211–1223. doi: 10.1242/dev.126.6.1211. [DOI] [PubMed] [Google Scholar]
  36. Yang Y, Topol L, Lee H, Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Dev. 2003;130:1003–15. doi: 10.1242/dev.00324. [DOI] [PubMed] [Google Scholar]
  37. Yin Y, Ma L. Development of the mammalian female reproductive tract. J Biochem. 2005;137:677–683. doi: 10.1093/jb/mvi087. [DOI] [PubMed] [Google Scholar]
  38. Zhao C, Aviles, Abel RA, Almli CR, McQuillen P, Pleasure SJ. Wnt7b activates canonical signaling in epithelial and vascular smooth muscle cells through interactions with Fzd1, Fzd10, and LRP5. Mol Cell Biol. 2005;25:5022–30. doi: 10.1128/MCB.25.12.5022-5030.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES